EMJ Podcast: Insights For Healthcare Professionals

In the final episode, Christopher Griffiths looks to the future of psoriasis research and care. From AI and global collaboration to improving access to advances in inflammatory skin disease, he explores the opportunities and challenges that could shape the next decade of psoriasis research.

Timestamps:

00:47 – Next decade of psoriasis research

03:33 – AI in psoriasis care

04:36 – Global collaboration

06:22 – Ensuring global access

How has psoriasis treatment changed beyond recognition? In Part 2, Christopher Griffiths discusses advances in treatment, precision medicine, and biomarkers, alongside insights from PSORT and BADBIR. He explores how real-world evidence complements clinical trials and how treatment success has evolved to focus on improving patients' lives.

Timestamps:

00:46 – Changing treatment landscape

02:05 – Precision medicine in psoriasis

03:19 – Promising biomarkers

07:16 – BADBIR

09:09 – Clinician and patient relationship

10:02 – Definition of treatment success

Christopher Griffiths joins host Saranya Ravindran to explore how our understanding of psoriasis has evolved from a disorder of skin cell proliferation to a complex immune-mediated inflammatory disease. Discover the breakthroughs that transformed psoriasis research and why the condition has become a model for understanding inflammation.

Timestamps:

00:56 – Previous understanding of psoriasis

01:57 – Psoriasis as an immune-mediated disease

03:30 – Psoriasis as a model disease

04:14 – International Psoriasis Council

05:41 – Unanswered questions in psoriasis

In this rapid-fire episode, Christopher Griffiths answers key questions about psoriasis, from what first drew him to the disease and the biggest changes in our understanding to the scientific breakthroughs transforming patient care. He also considers whether psoriasis could one day be prevented and what unanswered questions remain.

In the final episode of the series, Monica McLemore discusses nursing leadership, research translation, community partnership, and the future of reproductive healthcare. Drawing on her experience across clinical nursing, public health, academia, and policy, she explores how evidence can influence practice, why accessible science communication matters, and how nurses can help advance reproductive justice.

Timestamps:

48:52 – Shaping reproductive healthcare across settings

52:16 – Translating research into practice and policy

57:44 – Making health equity research accessible

61:02 – Nursing's role in advancing reproductive justice

64:51 – The future of reproductive and maternal healthcare

Monica McLemore joins host Catherine Glass to explore the persistent racial inequities affecting maternal health. From structural racism and barriers within healthcare systems to racism experienced in neonatal intensive care, this episode examines why disparities persist and how clinicians, researchers, and communities can work together to create meaningful change.

Timestamps:

05:02 – Drivers of racial inequities in maternal health

07:58 – Structural barriers to equitable pregnancy care

12:38 – Racism in neonatal intensive care

16:15 – Becoming an agent for healthcare change

21:25 – Moving beyond disparity documentation

25:51 – The role of community-engaged research

Monica McLemore joins host Catherine Glass to explore the persistent racial inequities affecting maternal health. From structural racism and barriers within healthcare systems to racism experienced in neonatal intensive care, this episode examines why disparities persist and how clinicians, researchers, and communities can work together to create meaningful change.

Timestamps:

05:02 – Drivers of racial inequities in maternal health.

07:58 – Structural barriers to equitable pregnancy care.

12:38 – Racism in neonatal intensive care.

16:15 – Becoming an agent for healthcare change.

21:25 – Moving beyond disparity documentation.

25:51 – The role of community-engaged research.

In this quickfire episode, Monica McLemore answers key questions about reproductive justice and maternal health equity, from the biggest challenges facing maternity care and misconceptions about health inequities to abortion care, healthcare leadership, and what gives her hope for the future. A concise introduction to the key themes explored throughout the series.

In the final episode of this series, Anita Charlesworth draws on her experience across the Treasury, the Department of Health, and NHS leadership to assess Britain's readiness for the next decade — from lessons still unlearned from COVID-19 to the interconnected risks of workforce shortages, poor population health, and economic inactivity.

Timestamps:

00:00 – 00:54: Introduction
00:54 – 03:28: NHS Readiness
03:28 – 04:50: COVID-19 Lessons
04:50 – 06:18: Market Failures
06:18 – 07:35: Economic Risks
07:35 – 09:15: Investment Priorities
09:15 – 10:50: NHS 2035

What does productivity really mean in the NHS? In Part 2, Anita Charlesworth explores the biggest barriers to getting more health from the same resources, the real role technology, data, and AI can play, and where the greatest opportunities lie for improving productivity without compromising care.

Timestamps:

00:00 – 01:04: Introduction
01:04 – 04:19: Defining Productivity
04:19 – 06:25: NHS Productivity
06:25 – 09:18: AI Solutions?
09:18 – 14:13: Improving Productivity

Anita Charlesworth joins host Saranya Ravindran to explore how the NHS measures success. From the limits of waiting-time targets to what "value" really means in healthcare, this episode unpacks how a smarter performance framework could better capture prevention, quality of life, and wider social outcomes.

Timestamps:

00:00 – 01:02: Introduction
01:02 – 04:36: Measuring Outcomes
04:36 – 06:16: Overlooked Outcomes
06:16 – 07:19: Defining "Value"
07:19 – 10:31: Assessing Prevention
10:31 – 13:24: Encouraging Change

In this rapid-fire episode, Anita Charlesworth answers key questions on the future of the NHS; from the biggest threat to its long-term sustainability to the most misunderstood concept in health economics. Perfect for listeners short on time but eager for a sharp, honest take on the state of the health service.

In the final episode, Professor Devaki Nair explores how community-based screening programmes can improve cardiovascular risk detection among underserved populations. The discussion covers healthcare inequalities, barriers to lipid target achievement, and practical solutions for delivering cardiovascular prevention at scale.

Timestamps:

00:00 – 00:53: Introduction
00:53 – 03:46: Community Initiatives
03:46 – 05:24: Undeserved Populations
05:24 – 06:52: Health Inequalities
06:52 – 10:16: Real-World Barriers
10:16 – 11:35: Future Prevention

Why has Lipoprotein(a) emerged as one of the hottest topics in preventive cardiology? In Part 2, Professor Devaki Nair explains when clinicians should measure Lipoprotein(a), how elevated levels influence cardiovascular risk, and how emerging targeted therapies could transform prevention strategies in the coming decade.

Timestamps:

00:00 – 00:40: Introduction
00:40 – 03:03: Lipoprotein(a)'s Rise
03:03 – 04:58: Measuring Lipoprotein(a)
04:58 – 08:04: Cardiovascular Risk
08:04 – 10:04: Targeted Therapies
09:28 – 12:12: Patient Referral

Professor Devaki Nair joins host Catherine Glass to discuss why familial hypercholesterolaemia remains underdiagnosed despite increasing awareness. Learn how genetic testing, cascade screening, and specialist lipid clinics are helping clinicians identify high-risk families earlier and improve the prevention of premature cardiovascular disease.

Timestamps:

00:00 – 00:52: Introduction

00:52 – 04:50: Diagnostic Barriers

04:50 – 06:18: Genetic Testing

06:18 – 08:15: Screening Barriers

08:15 – 10:04: Lesson Learned

10:04 – 11:02: New Developments

In this rapid-fire episode, Professor Devaki Nair answers key questions on cardiovascular prevention, cholesterol, Lipoprotein(a), familial hypercholesterolaemia, and the future of lipidology. Discover the biggest challenges, emerging trends, and opportunities shaping preventive cardiology in just a few minutes.

In the final episode of this series on colorectal cancer screening, Matt Rutter explores the future of early diagnosis and prevention. From AI in endoscopy and personalised screening pathways to emerging technologies and unanswered research questions, this episode looks at how innovation could transform bowel cancer detection and prevention over the next decade.

Timestamps:

58:09 – Innovations in colorectal cancer detection

05:10 – Personalised screening pathways

06:15 – Unanswered questions in colorectal cancer screening research

07:25 – One major change for healthcare systems to improve screening outcomes

07:57 – Colorectal cancer screening in 10–15 years

9:05 – The next 5 years i...

How do faecal immunochemical tests and colonoscopy work together to improve colorectal cancer detection? In Part 2, Matt Rutter discusses the importance of quality in endoscopy, including colonoscopy performance indicators, interval cancers, variation in outcomes, and the role of large-scale data in improving screening pathways. This episode highlights why quality improvement remains central to preventing colorectal cancer.

Timestamps

01:08 – Endoscopy quality

03:18 – Colonoscopy quality indicators

04:56 – Variations between colonoscopy providers

08:05 – The National Endoscopy Database

10:16 – Interval cancers

13:53 – Interpreting FIT Results

This episode has been funded by AstraZeneca and is intended for healthcare professionals. All content has been developed independently by AMJ, and AstraZeneca has had no influence over the content of this podcast. The views expressed are those of the participating experts and do not necessarily reflect the views of AMJ or AstraZeneca. This material is intended for educational and scientific exchange purposes only.

Thoracic medical oncologist Julia Rotow and neuro-oncologist David O. Kamson discuss how they manage central nervous system metastases in EGFR-mutated advanced non-small cell lung cancer. They begin with brain metastases found at diagnosis...

Professor Matt Rutter joins host Catherine Glass to explore the evolution of colorectal cancer screening, from the development of national bowel cancer screening programmes to the growing role of faecal immunochemical tests, colonoscopy, and polyp management. Drawing on lessons from more than two decades of screening, this episode examines how screening pathways have changed, how our approach to colorectal polyps has evolved, and how risk stratification could shape the future of colorectal cancer prevention.

Timestamps:

01:10 – Evolution of colorectal cancer screening

05:32 – FIT and colonoscopy

7:27 – Managing polyps

10:06 – Risk-based screening

In this rapid-fire episode, Matt Rutter answers key questions about colorectal cancer screening, from the importance of early detection and the role of faecal immunochemical tests to misconceptions about screening, colonoscopy quality, and the future of bowel cancer prevention. Perfect for listeners looking for concise insights into how screening is improving outcomes in colorectal cancer.

In the final episode, Linda Wesp explores the future of LGBTQIA+ healthcare. From clinician education and nursing leadership to healthcare policy and patient partnership, discover the changes needed to build more equitable and inclusive health systems.

Timestamps:

01:06 – Gaps in clinician training

04:04 - Practical changes

06:11 – The role of nursing in LGBTQIA+ health equity

08:04 – Community involvement in designing healthcare services

09:43 – Legislation changes

11:45 – The future of LGBTQIA+ healthcare

How has HIV care evolved over the past 2 decades? Linda Wesp reflects on lessons from the HIV epidemic, the importance of community partnership, reducing stigma in healthcare, and delivering person-centred care for people living with HIV.

Timestamps:

01:03 – The evolution of HIV care

06:23 – Lessons from the AIDS crisis

08:54 - The Wisconsin HIV/AIDS Oral History Project

10:31 – Reducing stigma in healthcare

14:06 – Holistic, patient-centred care

16:22 – Community voices

This content was funded by Johnson & Johnson. This material is intended for educational and scientific exchange purposes only. It is not intended to be promotional and should not be used to make treatment decisions for any individual patient. The views expressed are those of the speaker and do not necessarily reflect those of Johnson & Johnson.

Atypical EGFR mutations make up approximately 5 to 10% of EGFR-mutant NSCLC, and because some assays only report exon 19 deletions and L858R, they are easy to miss. In this short podcast, Melina Marmarelis, thoracic oncologist at the University of Pennsylvania, explains w...

In this quickfire episode, Linda Wesp answers rapid-fire questions on gender-affirming care, HIV, culturally safe healthcare, and LGBTQIA+ health. Discover practical insights on tackling stigma, improving clinician education, and creating more inclusive healthcare environments in just a few minutes.

Linda Wesp joins host Catherine Glass to discuss how clinicians can deliver culturally safe, gender-affirming healthcare across all areas of practice. From informed consent models and trauma-informed care to supporting patients who are transgender and gender-diverse, this episode explores practical approaches to improving healthcare experiences and outcomes.

Timestamps:

01:03 – The historical timeline of gender-affirming care

04:49 – Gender-affirming care outside of specialist clinics

07:06 - Breaking down misconceptions of gender-affirming care

09:25 – Informed consent models

13:30 – Culturally safe care

17:59 – Listening to transgender youth

In the final episode, Tonia Poteat discusses how healthcare systems can move beyond recognising health inequities to implement meaningful change. From community-engaged research and inclusive policy development to the future priorities for transgender health research, this episode explores practical strategies for advancing equitable healthcare. 

Timestamps: 

01:00 – Translating Evidence Into Practice 

05:30 – Policy Change and Challenging Healthcare Systems

Why do transgender communities continue to experience profound health inequities? In Part 2, Tonia Poteat examines the structural and social determinants influencing transgender health, the persistent disparities in HIV prevention and care, and the importance of addressing housing, employment, stigma, and gender affirmation alongside traditional healthcare interventions. 

Timestamps: 

01:01 – Political Determinants of Health 

04:00 – Gender and Racial Minorities – HIV 

06:04 – Why Intersectionality is

Sagar Lonial discusses advances in multiple myeloma treatment, the evolving role of immunotherapy and minimal residual disease, unmet needs in relapsed disease, lessons from research, and emerging technologies shaping future care. 

Timestamps: 

00:00 – Introduction 
01:24 – Inspiration for Myeloma Research 
03:20 – Transformative Myeloma Treatment Developments 
05:03 – Translating Science into Treatment 
07:41 – Future of Immunotherapy in Myeloma 

Tonia Poteat joins host Catherine Glass to explore how intersectionality provides a more complete understanding of health inequities. Together, they discuss why single-axis approaches often fail, how overlapping identities shape health outcomes, and how clinicians can begin applying intersectional thinking to improve patient care and healthcare research.

Timestamps:

01:00 – Intersectionality

02:26 – Why Intersectionality is Important in HIV Care

04:13 – Intersectionality and Gender-Diverse People

In this rapid-fire episode, Tonia Poteat answers key questions on intersectionality, transgender health, and health equity. Discover what drives her work in LGBTQIA+ health, common misconceptions surrounding transgender healthcare, the biggest challenges facing transgender communities today, and the practical steps healthcare organisations can take to become more inclusive in just a few minutes.

In the final episode of this series, Dr Carl Streed Jr explores the evolving evidence base, risk assessment, and policy landscape in transgender healthcare. From cardiovascular outcomes and research challenges to the interpretation of emerging evidence in healthcare and sport, this episode examines how clinicians, researchers, and policymakers can translate evidence into guidance while advancing inclusive, equitable care.

Timestamps:

01:00 – Cardiovascular Risk in Transgender Patients

04:29 – Sports Governing Bodies

06:05 – Methodological Challenges

07:26 – Translating Evidence into Guidance

How can clinical practice evolve to deliver more inclusive gender-affirming care? In Part 2, Carl Streed Jr shares insights from his research on implementing equitable healthcare, including the impact of targeted education, barriers to care delivery, and the role of training programmes in building long-term clinical competence. A must-listen for clinicians seeking to understand the evidence, practice, and future of transgender healthcare.

Timestamps:

01:08 – Providing Training on Gender Affirming Care

02:32 – Barriers to Gender Affirming Care

03:29 – Well-Rounded Gender-Affirming Care

04:45 – When to Look at Sex, and When to Look at Affirmed Gender?

06:27...

Carl Streed Jr joins host Catherine Glass to explore how healthcare systems can advance equity and inclusion for sexual and gender minority populations. From improving continuity of care and electronic health record design to addressing structural disparities and embedding equity at a systems level, this episode examines how research and implementation can transform LGBTQIA+ healthcare.

Timestamps:

01:02 – Continuity of Care

02:06 – Reshaping Electronic Health Records

04:08 – Equity at a Systems Level

In this rapid-fire episode, Carl Streed Jr answers key questions about transgender healthcare and LGBTQIA+ health equity, from the biggest barriers and research priorities to clinical training, inclusive practice, and the future of gender-affirming care. Perfect for listeners looking for concise insights into the challenges and opportunities shaping equitable healthcare.

This episode was funded by Stemline Therapeutics, Inc., a Menarini Company Group, and is intended for United States healthcare professionals only.

The opinions expressed here are solely those of the named speaker and do not represent those of his affiliated institution. His participation in this discussion does not constitute, and should not be construed as, endorsement, recommendation, or promotion of any product, service, or organization.

In this podcast, we shine a light on blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and highly aggressive hematologic malignancy.

Before 2018, there were no approved treatments for...

In the final episode of this series, Angela Frazer-Wicks MBE reflects on her journey from trauma and loss to advocacy and system change. She discusses the value of peer support, the importance of incorporating lived experience into service design, and the progress made in understanding maternal vulnerability. This episode offers practical insights into building more compassionate, preventative, and trauma-informed systems for women and families.

Timestamps:

00:00–00:42: Intro

00:43–05:06: New beginnings

05:07–09:49: Lived experiences

09:50–14:49: Peer support

14:50–19:49: Care reforms

19:50–20:16: Outro 

What are the health impacts of child removal and family separation? In Part 2 of this series, Angela Frazer-Wicks MBE discusses the often overlooked psychological and emotional consequences of child removal and family separation. She shares insights into grief, stigma, shame, and the long-term impact these experiences can have on maternal wellbeing. This episode explores gaps in support services and highlights the crucial role healthcare professionals can play in helping mothers navigate loss and recovery.

Timestamps:

00:00–00:44: Intro

00:45–06:42: Unresolved grief

06:43–09:54: Overcoming shame

09:55–11:19: Mental support

11:20–13:56: HCP advocacy

13:57–17:07: Building trust